EMN Eastman Chemical
Eastman Chemical earnings company data as of 3:06 PM ET 10/30
- 0 of 1 EPS beats
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 29 Oct | EPS | 1.92 | 1.84 | Miss -4.2% |
| Rev | $2.40B | $2.39B | Miss -0.8% |
Insider trades
Open-market buys and sales by EMN's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $366K sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
Adrian James Holt SVP, Chf HR OfcrSale$234K 3,283 shares at $71.31 100% of stakeTraded Aug 4 Filed Aug 6
-
Adrian James Holt SVP, Chf HR OfcrSale$132K 1,709 shares at $77.05 100% of stakeTraded May 5 Filed May 7
Also filed in the last 12 months, not counted as buying or selling: 16 stock grants, 12 share withholdings for taxes, 3 gifts, and 2 option exercises.
SEC filings
Recent issuer filings from EDGAR, 11 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.03,8.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.